<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">nefr-122</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ И ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS AND LECTURES</subject></subj-group></article-categories><title-group><article-title>Клеточная физиология повреждения и восстановления почек</article-title><trans-title-group xml:lang="en"><trans-title>Cellular physiology of kidney injury and repair</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Золотухин</surname><given-names>П. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zolotukhin</surname><given-names>P. V.</given-names></name></name-alternatives><email xlink:type="simple">p.zolotukhin@icloud.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Беланова</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Belanova</surname><given-names>A. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лебедева</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Lebedeva</surname><given-names>U. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Батюшин</surname><given-names>М. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Batiushin</surname><given-names>M. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чистяков</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Chistyakov</surname><given-names>V. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Южный федеральный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Academy of biology and biotechnology, Southern federal university</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Южный федеральный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov state medical university</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>01</day><month>09</month><year>2015</year></pub-date><volume>19</volume><issue>5</issue><fpage>17</fpage><lpage>22</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Золотухин П.В., Беланова А.А., Лебедева Ю.А., Батюшин М.М., Чистяков В.А., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Золотухин П.В., Беланова А.А., Лебедева Ю.А., Батюшин М.М., Чистяков В.А.</copyright-holder><copyright-holder xml:lang="en">Zolotukhin P.V., Belanova A.A., Lebedeva U.A., Batiushin M.M., Chistyakov V.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/122">https://journal.nephrolog.ru/jour/article/view/122</self-uri><abstract><p>Потеря клеточности, а также гибель клеток с высвобождением их содержимого с последующим развитием патологических иммунных реакций - центральные элементы острого повреждения почек. В настоящем обзоре рассматриваются роли отдельных видов нарушения функционирования и гибели клеток почек, механизмы регенерации поврежденной ткани на уровне клетки, а также перспективы развития терапевтических технологий, основанных на блокировке гибели клеток и активации регенерации тканей почек.</p></abstract><trans-abstract xml:lang="en"><p>Loss of cellularity, massive cell death with its contents release and following pathologic immune response development. -acute kidney injury central elements. This review is focused on roles of systemic cell dysfunctions and cell death forms, cellular tissue repair mechanisms, as well as future development of therapeutic approaches based on cell death blocking and kidney tissue regeneration activation.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>апоптоз</kwd><kwd>некроз</kwd><kwd>аутошизис</kwd><kwd>регенерация</kwd><kwd>восстановление тканей</kwd><kwd>острое повреждение почек</kwd><kwd>эндосома</kwd><kwd>адаптерный белковый комплекс</kwd></kwd-group><kwd-group xml:lang="en"><kwd>NF-kappaB</kwd><kwd>apoptosis</kwd><kwd>necrosis</kwd><kwd>autoschizis</kwd><kwd>regeneration</kwd><kwd>tissue repair</kwd><kwd>acute kidney injury</kwd><kwd>NF-kappaB</kwd><kwd>endosome</kwd><kwd>adaptor protein complex</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Li B, Castano AP, Hudson TE et al. The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair. FASEB J 2010; 24 (12)· 4767-4781</mixed-citation><mixed-citation xml:lang="en">Li B, Castano AP, Hudson TE et al. The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair. FASEB J 2010; 24 (12)· 4767-4781</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Duffield JS, Hong S, Vaidya VS et al. Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol 2006; 177 (9)· 5902-5911</mixed-citation><mixed-citation xml:lang="en">Duffield JS, Hong S, Vaidya VS et al. Resolvin D series and protectin D1 mitigate acute kidney injury. J Immunol 2006; 177 (9)· 5902-5911</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang J, Lou X, Jin L et al. Necrosis, and then stress induced necrosis-like cell death, but not apoptosis, should be the preferred cell death mode for chemotherapy· clearance of a few misconceptions. Oncoscience 2014; 1 (6)· 407-422</mixed-citation><mixed-citation xml:lang="en">Zhang J, Lou X, Jin L et al. Necrosis, and then stress induced necrosis-like cell death, but not apoptosis, should be the preferred cell death mode for chemotherapy· clearance of a few misconceptions. Oncoscience 2014; 1 (6)· 407-422</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Silva MT. Secondary necrosis· the natural outcome of the complete apoptotic program. FEBS Lett 2010; 584 (22)· 4491-4499</mixed-citation><mixed-citation xml:lang="en">Silva MT. Secondary necrosis· the natural outcome of the complete apoptotic program. FEBS Lett 2010; 584 (22)· 4491-4499</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Festjens N, Vanden Berghe T, Cornelis S, Vandenabeele P. RIP1, a kinase on the crossroads of a cell’s decision to live or die. Cell Death Differ 2007; 14 (3)· 400-410</mixed-citation><mixed-citation xml:lang="en">Festjens N, Vanden Berghe T, Cornelis S, Vandenabeele P. RIP1, a kinase on the crossroads of a cell’s decision to live or die. Cell Death Differ 2007; 14 (3)· 400-410</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Vanden Berghe T, Linkermann A, Jouan-Lanhouet S et al. Regulated necrosis· the expanding network of non-apoptotic cell death pathways. Nat RevMol Cell Biol 2014; 15 (2)· 135-147</mixed-citation><mixed-citation xml:lang="en">Vanden Berghe T, Linkermann A, Jouan-Lanhouet S et al. Regulated necrosis· the expanding network of non-apoptotic cell death pathways. Nat RevMol Cell Biol 2014; 15 (2)· 135-147</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Sawai H, Domae N. Discrimination between primary necrosis and apoptosis by necrostatin-1 in Annexin V-positive/ propidium iodide-negative cells. Biochem Biophys Res Commun 2011; 411 (3)· 569-573</mixed-citation><mixed-citation xml:lang="en">Sawai H, Domae N. Discrimination between primary necrosis and apoptosis by necrostatin-1 in Annexin V-positive/ propidium iodide-negative cells. Biochem Biophys Res Commun 2011; 411 (3)· 569-573</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Jog NR, Caricchio R. The role of necrotic cell death in the pathogenesis of immune mediated nephropathies. Clin Immunol 2014; 153 (2)· 243-253</mixed-citation><mixed-citation xml:lang="en">Jog NR, Caricchio R. The role of necrotic cell death in the pathogenesis of immune mediated nephropathies. Clin Immunol 2014; 153 (2)· 243-253</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Тугушева ФА, Зубина ИМ. Оксидативный стресс и его участие в неиммунных механизмах прогрессирования хронической болезни почек. Нефрология 2009; (3)· 42-48 [Tugusheva FA, Zubina IM. Oksidativnyj stress i ego uchastie v neimmunnyh mehanizmah progressirovanija hronicheskoj bolezni pochek. Nefrologija 2003; (3)· 42-48]</mixed-citation><mixed-citation xml:lang="en">Тугушева ФА, Зубина ИМ. Оксидативный стресс и его участие в неиммунных механизмах прогрессирования хронической болезни почек. Нефрология 2009; (3)· 42-48 [Tugusheva FA, Zubina IM. Oksidativnyj stress i ego uchastie v neimmunnyh mehanizmah progressirovanija hronicheskoj bolezni pochek. Nefrologija 2003; (3)· 42-48]</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Z, Havasi A, Gall J et al. GSK3beta promotes apoptosis after renal ischemic injury. J Am Soc Nephrol 2010; 21 (2)· 284-294</mixed-citation><mixed-citation xml:lang="en">Wang Z, Havasi A, Gall J et al. GSK3beta promotes apoptosis after renal ischemic injury. J Am Soc Nephrol 2010; 21 (2)· 284-294</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Золотухин ПВ, Чмыхало ВК, Макаренко МС и др. Положительный контур мочевой кислоты, гомоцистеина, NOX и XOR· нефрологические аспекты. Нефрология 2014; (5)· 16-22 [Zolotukhin PV, Chmykhalo VK, Makarenko MS et al. Polozhitel'nyj kontur mochevoj kisloty, gomocisteina, NOX i XOR· nefrologicheskie aspekty. Nefrologija 2014; (5)· 16-22]</mixed-citation><mixed-citation xml:lang="en">Золотухин ПВ, Чмыхало ВК, Макаренко МС и др. Положительный контур мочевой кислоты, гомоцистеина, NOX и XOR· нефрологические аспекты. Нефрология 2014; (5)· 16-22 [Zolotukhin PV, Chmykhalo VK, Makarenko MS et al. Polozhitel'nyj kontur mochevoj kisloty, gomocisteina, NOX i XOR· nefrologicheskie aspekty. Nefrologija 2014; (5)· 16-22]</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Золотухин ПВ, Александрова АА, Довжик АД и др. Интерактомика - аналитический инструмент для изучения молекулярных основ нефропатий. Нефрология 2013; (5)· 9-15 [Zolotukhin PV, Aleksandrova AA, Dovzhik AD et al. Interactomics analytical tool for studying the molecular basis of nephropathy. Nefrologija 2013; (5)· 9-15]</mixed-citation><mixed-citation xml:lang="en">Золотухин ПВ, Александрова АА, Довжик АД и др. Интерактомика - аналитический инструмент для изучения молекулярных основ нефропатий. Нефрология 2013; (5)· 9-15 [Zolotukhin PV, Aleksandrova AA, Dovzhik AD et al. Interactomics analytical tool for studying the molecular basis of nephropathy. Nefrologija 2013; (5)· 9-15]</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Liang X, Chen X Zhang L et al. Necroptosis, a novel form of caspase-independent cell death, contributes to renal epithelial cell damage in an ATP-depleted renal ischemia model. Mol Med Rep 2014; 10 (2): 719-724</mixed-citation><mixed-citation xml:lang="en">Liang X, Chen X Zhang L et al. Necroptosis, a novel form of caspase-independent cell death, contributes to renal epithelial cell damage in an ATP-depleted renal ischemia model. Mol Med Rep 2014; 10 (2): 719-724</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Zolotukhin P, Kozlova Y, Dovzhik A et al. Oxidative status interactome map: towards novel approaches in experiment planning, data analysis, diagnostics and therapy. Mol Biosyst 2013; 9 (8): 2085-2096</mixed-citation><mixed-citation xml:lang="en">Zolotukhin P, Kozlova Y, Dovzhik A et al. Oxidative status interactome map: towards novel approaches in experiment planning, data analysis, diagnostics and therapy. Mol Biosyst 2013; 9 (8): 2085-2096</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Pavlides S, Vera I, Gandara R et al. Warburg meets autoph-agy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis. Antioxid Redox Signal 2012; 16 (11): 1264-1284</mixed-citation><mixed-citation xml:lang="en">Pavlides S, Vera I, Gandara R et al. Warburg meets autoph-agy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis. Antioxid Redox Signal 2012; 16 (11): 1264-1284</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Беланова АА, Лебедева ЮА, Кузьминова ОН и др. Активаторный белок 1: структура, функционирование и роль в окислительном статусе человека. Валеология 2014; (3): 1120 [Belanova AA, Lebedeva UA, Kuz’minova ON et al. Activator protein 1: structure, functioning and role in the oxidative status of a person. Valeologija 2014; (3): 11-20]</mixed-citation><mixed-citation xml:lang="en">Беланова АА, Лебедева ЮА, Кузьминова ОН и др. Активаторный белок 1: структура, функционирование и роль в окислительном статусе человека. Валеология 2014; (3): 1120 [Belanova AA, Lebedeva UA, Kuz’minova ON et al. Activator protein 1: structure, functioning and role in the oxidative status of a person. Valeologija 2014; (3): 11-20]</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Jain AK, Jaiswal AK. GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J Biol Chem 2007; 282 (22): 16502-16510</mixed-citation><mixed-citation xml:lang="en">Jain AK, Jaiswal AK. GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J Biol Chem 2007; 282 (22): 16502-16510</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Funk JA, Schnellmann RG. Accelerated recovery of renal mitochondrial and tubule homeostasis with SIRT1/PGC-1 α activation following ischemia-reperfusion injury. Toxicol Appl Pharmacol 2013; 273 (2): 345-354</mixed-citation><mixed-citation xml:lang="en">Funk JA, Schnellmann RG. Accelerated recovery of renal mitochondrial and tubule homeostasis with SIRT1/PGC-1 α activation following ischemia-reperfusion injury. Toxicol Appl Pharmacol 2013; 273 (2): 345-354</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Fan H, Yang HC, You L et al. The histone deacetylase, SIRT1, contributes to the resistance of young mice to ischemia/ reperfusion-induced acute kidney injury. Kidney Int 2013; 83 (3): 404-413</mixed-citation><mixed-citation xml:lang="en">Fan H, Yang HC, You L et al. The histone deacetylase, SIRT1, contributes to the resistance of young mice to ischemia/ reperfusion-induced acute kidney injury. Kidney Int 2013; 83 (3): 404-413</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Nakatsu F, Ohno H. Adaptor protein complexes as the key regulators of protein sorting in the post-Golgi network. Cell Struct Funct 2003; 28 (5): 419-429</mixed-citation><mixed-citation xml:lang="en">Nakatsu F, Ohno H. Adaptor protein complexes as the key regulators of protein sorting in the post-Golgi network. Cell Struct Funct 2003; 28 (5): 419-429</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Funato X Miki H. Redox regulation of Wnt signalling via nucleoredoxin. Free Radic Res 2010; 44 (4): 379-388</mixed-citation><mixed-citation xml:lang="en">Funato X Miki H. Redox regulation of Wnt signalling via nucleoredoxin. Free Radic Res 2010; 44 (4): 379-388</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Manea A, Manea SA, Gafencu AV et al. AP-1-dependent transcriptional regulation of NADPH oxidase in human aortic smooth muscle cells: role of p22phox subunit. Arterioscler Thromb Vasc Biol 2008; 28 (5): 878-885</mixed-citation><mixed-citation xml:lang="en">Manea A, Manea SA, Gafencu AV et al. AP-1-dependent transcriptional regulation of NADPH oxidase in human aortic smooth muscle cells: role of p22phox subunit. Arterioscler Thromb Vasc Biol 2008; 28 (5): 878-885</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Sanchez-Wandelmer J, Reggiori F. Amphisomes: out of the autophagosome shadow? EMBO J 2013; 32 (24): 3116-3118</mixed-citation><mixed-citation xml:lang="en">Sanchez-Wandelmer J, Reggiori F. Amphisomes: out of the autophagosome shadow? EMBO J 2013; 32 (24): 3116-3118</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнов АВ, Каюков ИГ, Дегтерева ОА и др. Проблемы диагностики и стратификации тяжести острого повреждения почек. Нефрология 2009; 13 (3): 9-18 [Smirnov AV, Kaiukov IG, Degtereva OA, Dobronravov VA, Rumyantcev ASh, Raffrafi TN, Zver'kov RV. Problemy' diagnostiki i stratifikatcii tiazhesti ostrogo povrezhdeniia pochek. Nefrologiia 2009; 13 (3): 9-18]</mixed-citation><mixed-citation xml:lang="en">Смирнов АВ, Каюков ИГ, Дегтерева ОА и др. Проблемы диагностики и стратификации тяжести острого повреждения почек. Нефрология 2009; 13 (3): 9-18 [Smirnov AV, Kaiukov IG, Degtereva OA, Dobronravov VA, Rumyantcev ASh, Raffrafi TN, Zver'kov RV. Problemy' diagnostiki i stratifikatcii tiazhesti ostrogo povrezhdeniia pochek. Nefrologiia 2009; 13 (3): 9-18]</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнов АВ, Каюков ИГ, Добронравов ВА, Румянцев АШ. Острое повреждение почек: концептуальные проблемы. Нефрология 2014; 18 (2): 8-24 [Smirnov AV, Kaiukov IG, Dobronravov VA, Rumyantcev ASh. Ostroe povrezhdenie pochek: kontceptual'ny'e problemy'. Nefrologiia 2014; 18 (2): 8-24]</mixed-citation><mixed-citation xml:lang="en">Смирнов АВ, Каюков ИГ, Добронравов ВА, Румянцев АШ. Острое повреждение почек: концептуальные проблемы. Нефрология 2014; 18 (2): 8-24 [Smirnov AV, Kaiukov IG, Dobronravov VA, Rumyantcev ASh. Ostroe povrezhdenie pochek: kontceptual'ny'e problemy'. Nefrologiia 2014; 18 (2): 8-24]</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
